These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 1465648

  • 21. Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5-year long-term Italian multicenter randomized clinical trial.
    Calvaruso G, Vitrano A, Di Maggio R, Lai E, Colletta G, Quota A, Gerardi C, Rigoli LC, Sacco M, Pitrolo L, Maggio A.
    Am J Hematol; 2015 Jul; 90(7):634-8. PubMed ID: 25809173
    [Abstract] [Full Text] [Related]

  • 22. Spinal deformities in deferoxamine-treated homozygous beta-thalassemia major patients.
    Hartkamp MJ, Babyn PS, Olivieri F.
    Pediatr Radiol; 1993 Jul; 23(7):525-8. PubMed ID: 8309754
    [Abstract] [Full Text] [Related]

  • 23. Modified desensitization protocols for a pediatric patient with anaphylactic reaction to deferoxamine.
    Surapolchai P, Poachanukoon O, Satayasai W, Silapamongkonkul P.
    J Med Assoc Thai; 2014 Aug; 97 Suppl 8():S217-22. PubMed ID: 25518318
    [Abstract] [Full Text] [Related]

  • 24. Combined chelation therapy with deferiprone and desferrioxamine in iron overloaded beta-thalassemia patients.
    Athanassiou-Metaxa M, Kousi A, Hatzipantelis ES, Tsatra I, Ikonomou M, Perifanis V, Tsantali H.
    Haematologica; 2004 Apr; 89(4):ELT07. PubMed ID: 15075120
    [No Abstract] [Full Text] [Related]

  • 25. Audiologic and vestibular assessment in patients with β-thalassemia major receiving long-term transfusion therapy.
    Chao YH, Wu KH, Lin CY, Tsai MH, Peng CT, Wu HP, Lin CD.
    Pediatr Blood Cancer; 2013 Dec; 60(12):1963-6. PubMed ID: 23956204
    [Abstract] [Full Text] [Related]

  • 26. Long-term intravenous deferoxamine treatment for noncompliant transfusion-dependent beta-thalassemia patients.
    Tamary H, Goshen J, Carmi D, Yaniv I, Kaplinsky C, Cohen IJ, Zaizov R.
    Isr J Med Sci; 1994 Aug; 30(8):658-64. PubMed ID: 8045754
    [Abstract] [Full Text] [Related]

  • 27. Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.
    Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Magnano C, Rizzo M, Caruso V, Gerardi C, Argento C, Campisi S, Cantella F, Commendatore F, D'Ascola DG, Fidone C, Ciancio A, Galati MC, Giuffrida G, Cingari R, Giugno G, Lombardo T, Prossomariti L, Malizia R, Meo A, Roccamo G, Romeo MA, Violi P, Cianciulli P, Rigano P.
    Blood Cells Mol Dis; 2009 Aug; 42(3):247-51. PubMed ID: 19233692
    [Abstract] [Full Text] [Related]

  • 28. Acute renal failure following deferoxamine overdose.
    Li Volti S, Maccarone C, Li Volti G, Romeo MA.
    Pediatr Nephrol; 2003 Oct; 18(10):1078-9. PubMed ID: 12920634
    [No Abstract] [Full Text] [Related]

  • 29. Marrow proliferation as a cause of hearing loss in beta-thalassaemia major.
    Thio D, Prasad V, Anslow P, Lennox P.
    J Laryngol Otol; 2008 Nov; 122(11):1253-6. PubMed ID: 17931455
    [Abstract] [Full Text] [Related]

  • 30. Renal dysfunction in patients with beta-thalassemia major receiving iron chelation therapy either with deferoxamine and deferiprone or with deferasirox.
    Economou M, Printza N, Teli A, Tzimouli V, Tsatra I, Papachristou F, Athanassiou-Metaxa M.
    Acta Haematol; 2010 Nov; 123(3):148-52. PubMed ID: 20185899
    [Abstract] [Full Text] [Related]

  • 31. Yersinia enterocolitica as a cause of intra-abdominal abscess: the role of iron.
    Pallister C, Rotstein OD.
    Can J Surg; 2001 Apr; 44(2):135-6. PubMed ID: 11308237
    [No Abstract] [Full Text] [Related]

  • 32. [The mechanism of cataract formation in persons with beta-thalassemia].
    Popescu C, Siganos D, Zanakis E, Padakis A.
    Oftalmologia; 1998 Apr; 45(4):10-3. PubMed ID: 10418622
    [Abstract] [Full Text] [Related]

  • 33. Rapid development of severe toxic retinopathy associated with continuous intravenous deferoxamine infusion.
    Lai TY, Lee GK, Chan WM, Lam DS.
    Br J Ophthalmol; 2006 Feb; 90(2):243-4. PubMed ID: 16424543
    [No Abstract] [Full Text] [Related]

  • 34. Nephrolithiasis in patients exposed to deferasirox and desferioxamine: probably an age-linked event with different effects on some renal parameters.
    Ricchi P, Ammirabile M, Costantini S, Spasiano A, Di Matola T, Cinque P, Casale M, Filosa A, Prossomariti L.
    Ann Hematol; 2014 Mar; 93(3):525-7. PubMed ID: 23807253
    [No Abstract] [Full Text] [Related]

  • 35. Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia.
    Aessopos A, Kati M, Tsironi M, Polonifi E, Farmakis D.
    Haematologica; 2006 May; 91(5 Suppl):ECR11. PubMed ID: 16709519
    [Abstract] [Full Text] [Related]

  • 36. Iron-chelation therapy with oral chelators in patients with thalassemia major.
    Uygun V, Kurtoglu E.
    Hematology; 2013 Jan; 18(1):50-5. PubMed ID: 23321010
    [Abstract] [Full Text] [Related]

  • 37. Daily alternating deferasirox and deferiprone therapy for "hard-to-chelate" beta-thalassemia major patients.
    Balocco M, Carrara P, Pinto V, Forni GL.
    Am J Hematol; 2010 Jun; 85(6):460-1. PubMed ID: 20513129
    [No Abstract] [Full Text] [Related]

  • 38. Current growth patterns in children and adolescents with thalassemia major.
    Origa R, Danjou F, Orecchia V, Zappu A, Dessì C, Foschini ML, Leoni GB, Moi P, Morittu M, Demurtas A, Loche S.
    Blood; 2016 Nov 24; 128(21):2580-2582. PubMed ID: 27737888
    [No Abstract] [Full Text] [Related]

  • 39. [Long-term follow-up and bone imaging in acquired osteochondrodysplasia in a female patient with thalassemia and desferrioxamine hypersensitivity].
    Mangiagli A, De Sanctis V, Campisi S, Di Silvestro G, Urso L.
    Minerva Pediatr; 2000 Apr 24; 52(4):235-41. PubMed ID: 11995208
    [Abstract] [Full Text] [Related]

  • 40. Pulmonary embolism and intravenous high-dose desferrioxamine.
    Cianciulli P.
    Haematologica; 1992 Apr 24; 77(4):368-9. PubMed ID: 1427452
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.